PC
ELV icon

PointState Capital’s Elevance Health ELV Stock Holding History

PointState Capital’s Portfolio ELV Stock Details ELV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-21,800
Closed -$6.26M – 126
2019
Q1 		$6.26M Buy
+21,800
New +$6.3M 0.12% 66

Other funds holding ELV

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Sanders Capital
Sanders Capital West Palm Beach, Florida $83.9B AUM 37.89% 1-Year Est. Return

PointState Capital's ELV Position: Q4 2021 in Review

PointState Capital sold out of Elevance Health (ELV) in Q4 2021, closing a stake of 37,500 shares — an estimated $14M sold.

PointState Capital first reported a position in ELV in Q4 2018 and held it in 8 quarters. The position peaked at $118M in Q1 2019. 1,372 funds tracked by Wall St. Rank hold ELV as of Q4 2021.

  • PointState Capital reported no remaining Elevance Health position as of Q4 2021 after selling out during the quarter.
  • PointState Capital sold 37,500 Elevance Health shares in Q4 2021, an estimated $14M.
  • PointState Capital first reported a position in Elevance Health in Q4 2018 and held it in 8 quarters.
  • PointState Capital's Elevance Health position peaked at $118M in Q1 2019.
  • 1,372 funds tracked by Wall St. Rank held Elevance Health as of Q4 2021.

Based on PointState Capital's 13F filing for Q4 2021, filed 11 Feb 2022.